Tower Research Capital LLC (Trc) Adc Therapeutics Sa Transaction History

Tower Research Capital LLC (Trc)

$3.39 Billion
Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,609 shares of ADCT stock, worth $22,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,609

Previous 12,779 56.11%

Holding current value

$22,211

Previous $34,000 35.29%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$2.64 - $4.02 $18,928 - $28,823	-7,170 Reduced 56.11%	5,609 $22,000
Q2 2025 Aug 14, 2025	BUY	$1.1 - $3.67 $2,909 - $9,707	2,645 Added 26.1%	12,779 $34,000
Q1 2025 May 15, 2025	BUY	$1.39 - $2.02 $6,306 - $9,164	4,537 Added 81.06%	10,134 $14,000
Q4 2024 Feb 13, 2025	BUY	$1.89 - $3.48 $1,797 - $3,309	951 Added 20.47%	5,597 $11,000
Q3 2024 Nov 14, 2024	BUY	$2.59 - $4.01 $12,033 - $18,630	4,646 New	4,646 $14,000

Q4 2023 Feb 13, 2024	BUY	$0.47 - $1.79 $4,944 - $18,832	10,521 Added 255.36%	14,641 $24,000
Q3 2023 Nov 14, 2023	SELL	$0.72 - $2.37 $1,152 - $3,794	-1,601 Reduced 27.98%	4,120 $3,000
Q2 2023 Aug 14, 2023	BUY	$1.9 - $2.66 $10,750 - $15,050	5,658 Added 8980.95%	5,721 $12,000
Q1 2023 May 09, 2023	SELL	$1.92 - $5.45 $5,514 - $15,652	-2,872 Reduced 97.85%	63 $0
Q4 2022 Feb 10, 2023	SELL	$2.87 - $5.24 $18,764 - $34,259	-6,538 Reduced 69.02%	2,935 $11,000
Q3 2022 Nov 10, 2022	BUY	$4.66 - $10.31 $40,882 - $90,449	8,773 Added 1253.29%	9,473 $46,000
Q2 2022 Aug 15, 2022	SELL	$5.96 - $14.99 $220 - $554	-37 Reduced 5.02%	700 $6,000
Q1 2022 May 12, 2022	SELL	$13.28 - $20.03 $19,282 - $29,083	-1,452 Reduced 66.33%	737 $10,000
Q4 2021 Feb 14, 2022	BUY	$19.29 - $31.51 $41,357 - $67,557	2,144 Added 4764.44%	2,189 $44,000
Q3 2021 Nov 15, 2021	BUY	$20.45 - $30.0 $920 - $1,350	45 New	45 $1,000
Q2 2021 Aug 16, 2021	SELL	$20.38 - $27.04 $1,671 - $2,217	-82 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$22.75 - $34.05 $102,852 - $153,940	-4,521 Reduced 98.22%	82 $2,000
Q4 2020 Feb 16, 2021	BUY	$25.26 - $38.02 $116,271 - $175,006	4,603 New	4,603 $147,000

Others Institutions Holding ADCT

# of Institutions

109

Shares Held

67.3M

Call Options Held

39.8K

Put Options Held

68.4K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $307M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Adc Therapeutics Sa Transaction History